Significats de diagnostic assay en anglès

Background: Real-time PCR has emerged as the preferred diagnostic assay for CMV.

Detection of these fusion genes could be a sensitive molecular diagnostic assay.

A vaccine that affords heterologous protection and a commercially-available molecular diagnostic assay are lacking.

CDC rapidly deployed a diagnostic assay for Ebola virus (EBOV) to public health laboratories.

A simple, cheap and fast diagnostic assay that is suitable for use in field conditions is highly desired.

So, there is currently an urgent need for a sensitive and specific diagnostic assay for detecting N. caninum in animals.

The availability of cell lines expressing paraneoplastic antigens offers an easy diagnostic assay which may complement or replace conventional immunohistochemistry.

This new technology opens up the possibility to automate and speed up an important and widely used diagnostic assay for bloodstream infections.

The proposed diagnostic assay offers a simple, rapid, specific, and cost-effective method for direct detection and identification of mycobacterial DNA in clinical samples.

Strategic design and suitable purification techniques are of paramount importance in the production of recombinant proteins, if intended for use in a diagnostic assay.

PCR used in combination with hybridisation analysis will provide a sensitive diagnostic assay to detect BLV when antibody tests give weakly positive or equivocal results.

These improvements include new diagnostic assays and therapies targeted at specific disease mediators.

Moreover, the approach described is applicable to other diagnostic assays with imperfect detection.

GeneThera has developed diagnostic assays for use in the agricultural and veterinary markets.

Nucleic acid amplification is the basis for many molecular diagnostic assays.

The consequences for 18S rRNA based diagnostic assays is discussed.